{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-047314","form_type":"8-K","ticker":null,"cik":"0000727207","company_name":"Accelerate Diagnostics, Inc","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.116710+00:00","generated_at":"2026-05-22T00:54:45.121283+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Accelerate Diagnostics to be delisted from Nasdaq after Chapter 11 filing; shares to trade OTC under AXDXQ","bullets":["Filed Chapter 11 bankruptcy on May 8, 2025; Nasdaq cited public interest concerns and bid price deficiencies.","Common stock suspended at Nasdaq open on May 15, 2025; company will not appeal delisting.","Expects to trade OTC under symbol AXDXQ starting May 15, 2025; no assurance OTC trading will continue.","Company warns holders of Securities face significant or complete loss on investment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-047314","json":"https://secwatch.observer/filing/0001104659-25-047314.json","markdown":"https://secwatch.observer/filing/0001104659-25-047314.md","text":"https://secwatch.observer/filing/0001104659-25-047314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/727207/000110465925047314/0001104659-25-047314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/727207/000110465925047314/tm2514740d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T00:54:45.121283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c4dec5a1ca2f2fd261e267fac415ff58f8799b5f","claim":"Accelerate Diagnostics, Inc received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1, 5550(a)(2), 5550(b)(2)).","evidence_excerpt":"”). On May 8, 2025, the Company received written notice (the “ Delisting Notice ”) from the Listing Qualifications Staff (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, as a result of the Bankruptcy Petitions and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the Staff has determined that the Company’s common stock (the “ Securities ”) will be delisted from Nasdaq. In addition, on May 6, 2025, the Company received written notice from the Staff notifying the Company that, for the last 30 consecutive business days, the closing bid pr","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925047314/0001104659-25-047314-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Rules","value":"5101, 5110(b), IM-5101-1, 5550(a)(2), 5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}